BeiGene, Ltd. - American Depositary Shares (BGNE)

Търговски условия

Търговска сесия (UTC)
понеделник: 11:00 - 00:00
вторник - петък: 00:00 - 00:30, 11:00 - 00:00
събота: 00:00 - 00:30

Относно

BeiGene Ltd is a clinical-stage biopharmaceutical company engaged in the discovery & development of molecularly targeted & immuno-oncology drugs for the treatment of cancer. Its product include BGB-3111, BGB-283 and BGB-290 and one immuno-oncology agent.

http://www.beigene.com/